新型3-(α-羟基吲哚亚甲基)吡咯烷-2,4-二酮衍生物的合成与除草活性研究

为了进一步研究3-羟亚甲基吡咯烷-2,4-二酮类化合物构效关系,以期发现高活性化合物,利用生物等排原理引入具有芳香性的吲哚环,合成了22个未见文献报道的新型3-羟亚甲基吡咯烷-2,4-二酮衍生物,其结构均经过1HNMR和元素分析确证.初步生物活性测试结果表明,这些化合物均具有一定的除草活性.初步的构效关系研究表明,该类吡咯烷-2,4-二酮类化合物的除草活性与平面A和B的相对构型有关.     

3-取代苄基-6-三氟甲基嘧啶-2,4(1H,3H)-二酮衍生物的合成及其除草活性的研究

为了进一步研究3-取代苄基-6-三氟甲基嘧啶-2,4(1H,3H)-二酮衍生物的除草活性, 以期发现更高活性化合物, 合成了16个未见文献报道的3-取代苄基-6-三氟甲基嘧啶-2,4(1H,3H)-二酮衍生物, 其结构均经过¹H NMR, IR和元素分析确证. 生测结果表明, 嘧啶环1-位取代基的变化, 不仅影响化合物的抑制活性与选择性, 可能还改变了化合物的作用方式. 定量的结构与活性关系研究表明, 当作用对象为油菜时, 化合物的活性可能主要与取代基R的摩尔分子折射常数有关; 当作用对象为稗草时, 化合物的活性可能主要与取代基R的电性参数有关. 1-位为氢时, 有利于对油菜生长的抑制; 1-位为甲基时, 有利于对稗草生长的抑制.     

1-苄基-3-[α-羟基-(未)取代苄基叶立德]吡咯啉- 2,4-二酮的合成与生物活性

为了发现具有高除草活性的对羟基苯基丙酮酸双氧化酶抑制剂(简称HPPD, EC 1.13. 11.27), 利用由不同的芳香羧酸和乙酰乙酸乙酯为原料得到的不同的β-酮酸酯与N-苄基甘氨酸乙酯反应得到12个未见文献报道的1-苄基-3-[α-羟基-(未)取代苄基叶立德]吡咯啉-2,4-二酮化合物, 其结构均经过¹H NMR, IR和元素分析确证. 在活性测定方面, 采用了对不同的作用机制敏感的油菜平皿法和稗草小杯法. 初步生物活性测试结果表明, 其生长抑制活性高于对照药HPPD抑制剂磺草酮. 但磺草酮所表现出来的明显白化作用, 在这一类化合物只显示出微弱的缺绿现象, 这也许说明所合成的化合物除显示出较弱的HPPD抑制剂的特征外, 可能还具有生长抑制作用, 而且活性与结构之间存在着一定的构效关系.     

盐酸吡格列酮的合成新方法研究

报道了治疗糖尿病药物盐酸吡格列酮的合成新方法.在六氢吡啶作用下,对羟基苯甲醛和2,4-噻唑烷二酮缩合生成5-[(4-羟苯基)亚甲基]-2,4-噻唑烷二酮,经钯炭催化氢化还原生成5-[(4-羟苯基)甲基]-2,4-噻唑烷二酮,再和氢氧化钾反应生成相应的钾盐,然后与5-乙基-2-羟乙基吡啶和甲基磺酰氯反应得到的磺酸酯作用生成吡格列酮,最后用盐酸酸化得到其盐酸盐.产品结构经1H NMR和IR确证.     

5-(3-吲哚基)亚甲基噻唑烷-2,4-二酮衍生物的合成及体外抗肿瘤活性探索

将N-取代吲哚-3-甲醛和2,4-噻唑烷二酮通过亚甲基键合,再对噻唑烷二酮氮取代,合成了一系列5-(3-吲哚基)亚甲基噻唑烷-2,4-二酮衍生物(e1-e9).采用IR,1H NMR和HRMS对其结构进行了表征;采用MTT法对目标物抑制5种癌细胞增殖活性进行了测试.结果表明,所有目标物对A549、HCT116和PC-9表现出抑制活性,其中吲哚氮被苄基取代的化合物e1和e3对测定的癌细胞增殖抑制活性与5-氟尿嘧啶(5-FU)相近,并且对A549和HCT116表现出中等的抑制活性(IC50<30μM)。     

2-氰基-2,3,3-三甲基-5-硫代-吡咯烷的合成新法

以3,3-二甲基-4-戊烯酸甲酯为原料, 经过6步反应合成了目标产物2-氰基-2,3,3-三甲基-5-硫酮-吡咯烷, 反应的总收率约为37%, 其中关键步骤为分子内环化和碘化氢消除反应. 通过元素分析, ¹H NMR, IR和MS对所合成化合物的结构进行了表征.     

C(3)-乙烯基的化学修饰与含氧基团取代的叶绿素-a衍生物的合成

以焦脱镁叶绿酸-a甲酯为起始原料, 通过加成和氧化反应将其3-位上的乙烯基转化为羟乙基、溴乙基、二羟乙基、二溴乙基和溴羟乙基, 再经过二甲亚砜/乙酸酐或者高钌酸四丙基铵(TPAP)/N-甲基吗啉-N-氧化物所组成的混合氧化剂的氧化反应, 得到多种C(3)-多酮基取代的二氢卟吩衍生物. 其单羟基作为离去基团与不同的活泼亚甲基化合物经过重排过程, 得到相应的酮基取代的二氢卟吩衍生物. 所得新叶绿素衍生物的化学结构均经UV, IR, ¹H NMR及元素分析得以证实, 并对相应的反应提出可能的反应机理.     

5-(4-羟基苯基)-2,4-咪唑啉二酮酯类化合物的合成及其生物活性

在模拟AdSS酶天然抑制剂结构合成5-(4-羟基苄基)-2,4-咪唑啉二酮酯系列化合物的基础上,为优化其结构,以5-(4-羟基苯基)-2,4-咪唑啉二酮为中间体,合成了28个未见文献报道的5-(4-羟基苯基)-2,4-咪唑啉二酮羧酸酯类化合物,它们的结构均经IR,1HNMR和元素分析表征.初步生物活性测试表明目标化合物5-(4-羟基苯基)-2,4-咪唑啉二酮对叔丁基苯甲酸酯(2i)和2-噻吩酸酯(3b)在浓度200μg/mL时对拟南芥生长抑制率达70%..     

6-氨基-2-取代吲哚-3-羧酸乙酯及其衍生物的合成与生物活性评价

以2,4-二硝基氯苯和乙酰乙酸乙酯为原料, 经过亲核置换、还原-环化协同反应, 合成了6-氨基-2-甲基吲哚-3-羧酸乙酯, 而后在催化剂作用下, 与乙酰乙酸乙酯反应生成烯胺, 环化合成9-羟基-2,7-二甲基吡咯(2,3-f)喹啉-3-羧酸乙酯; 类似地, 合成了6-氨基-2-苯基吲哚-3-羧酸乙酯和6-氨基-2-(呋喃-2'-基)吲哚-3-羧酸乙酯. 其结构均由¹H NMR, IR以及MS波谱数据表征. 所得化合物具有抑制肺癌A549细胞生长的活性, 其抑制效果具有浓度依赖性.     

5-(色酮-3-亚甲基)-3-芳基硫乙内酰脲的合成

以α-氨基乙酸和芳基异硫氰酸酯为起始原料制备3-芳基-2-硫乙内酰脲, 然后在酸性条件下与3-甲酰基色酮发生类Knoevenagel缩合反应, 合成得到了16种新的5-(色酮-3-亚甲基)-3-芳基硫乙内酰脲类化合物. 所有化合物的结构均经IR, ¹H NMR, LC-MS和元素分析确证, 并做了初步的生理活性测试     

Studies on Silicon-Containing Fragrance Raw Materials( Ⅱ )——Syntheses and Odors of 4-Trimethylsilylcyclohex-3-enol and 4-Trimethylsilylcyclohexanol Derivatives

1-Substituted- 4-trimethylsilylcyclohex- 3-enol and 1-substituted- 4-trimetnylsilyl-cyclohexanol, 4-trimethylsilylcyclohex-3-enol and 4-trimethylsilylcyclohexanol, and some of their esters and carbon counterparts were synthesized. Structures of the nineteen new compounds were determined by 1H NMR, IR and MS. Their odors are evaluated.     

Spathoside, a cerebroside and other antibacterial constituents of the stem bark of Spathodea campanulata

Spathoside, a new cerebroside was isolated from the stem bark of Spathodea campanulata, besides known compounds (n-alkanes, linear aliphatic alcohols, sitosterol and their esters, beta-sitosterol-3-O-beta-D-glucopyranoside, oleanolic acid, pomolic acid, p-hydroxybenzoic acid and phenylethanol esters). The structures of the isolated compounds were established by spectroscopic studies. The antibacterial activity of the isolated compounds against a wide range of microorganisms was examined. They inhibited significantly the growth of some gram-positive and -negative bacteria.     

Mass spectrometry of N-substituted amino acids and their derivatives: Correlation of the abundances of the M+. and selected fragment ions of metamers

The mass spectral fragmentations of nineteen new metameric N-(E)-stilbenyloxyalkylcarbonyl- [or (E)-(4′-chlorostilbenyloxyalkylcarbonyl)]-substituted amino acids and their metameric methyl esters and hydrazides were investigated. Fragmentation pathways are proposed on the basis of accurate mass and metastable transition measurements. The correlation between the intensities of M^+. and the selected fragment ions of these compounds is discussed. The data obtained create the basis for distinguishing metamers.     

Synthesis and Antitumor Activity of Heterocycles Related to Carbendazim

Three types of compounds were synthesized from carbendazim ( 1 ), a benzimidazole derivative (Scheme 1 ). They included a group of esters at N1 prepared by treating carbendazim with isocyanates bearing ester groups ( 2a , 2b , 2c ), carboxyalkyl‐1,2,3,4‐tetrahydro‐s‐triazino[1,2‐a]benzimidazole‐2,4‐dione esters ( 3a and 3b , 3d and 3c derived from 3a . The antitumor potencies of the N1 esters were in the range of 7 to 40 μM, which compares favorably with carbendazim, but their water solubilities were low. The s‐triazine derivatives showed activity against pancreatic tumor cells, and one of them ( 3b ) was active in mice, but they were not effective against other tumor types. Treatment of carbendazim with 3‐bromopropionyl chloride produced 1‐methoxycarbonyl‐4‐oxo‐1,2,3,4‐tetrahydropyrimido[1,2‐a]benzimidazole ( 4 ), which gave 1‐(3‐aminopropionyl)benzimidazole 2‐methylcarbamates, substituted on the amino nitrogen ( 5a , 5b , and 5d ), when treated with amines. These products showed some antitumor activity in cell cultures, and an ethoxy derivative ( 5c ), obtained by treating 1‐methoxycarbonyl‐4‐oxo‐1,2,3,4‐tetrahydropyrimido[1,2‐a]benzimidazole with sodium ethoxide, was active in the 67–150 μM range. Some of the new compounds had good water solubility. Carbendazim kills tumor cells by inhibiting tubulin; however, s‐triazine 3b , which differs from it in size and functional groups, does not act by this mechanism.     

3-N-苄氧羰基-β-氨基丁酸糖酯的合成及生物活性

将两类具有重要生物活性的结构单元β-氨基丁酸和糖分子结合在一个分子内, 设计合成了8个新糖酯化合物. 经元素分析和1H NMR确认了其结构. 初步生物活性测定结果表明, 该类化合物具有一定的诱导活性, 且一些化合物的诱导活性比水杨酸的好.     

New composites of betulin esters with arabinogalactan as highly potent anti-cancer agents

Betulin and its esters are the natural compounds with high in vitro cytotoxicity toward many cancer cells. However, the poor water solubility of these compounds has limited their applications. We prepared new composites of betulin esters using two methods, namely ball-milling of the mixtures of betulin esters with arabinogalactan and preparation of thin films of these mixtures by evaporating the aqueous solutions. These composites revealed higher water solubility as compared with the initial substances without losing the structural integrity and functionality. As a result, the new composites have shown much higher inhibitory effects against different cancer cell lines such as Ehrlich ascites carcinoma cells and lung carcinoma cells (A549) in comparison with the initial substances. The cell viability studies based on Annexin V and Propidium iodide probes have confirmed the high proapoptotic effect of betulin ester derivatives against cancer cells.     

Synthesis and antitumor activity of heterocyclic acid ester derivatives of 20S-camptothecins

A series of heterocyclic acid esters of camptothecins as new compounds had been synthesized by acylation method,their in vitro and in vivo antitumor activities were evaluated.The cytotoxic results showed that 6 possessed the best efficacy on six human cancer cell lines in the six classes of CPTs' derivatives.In vivo testing results indicated that 9 had better antitumor activity against mouse liver carcinoma H_(22) than topotecan.     

含2-氯-5-吡啶甲基的双氰基取代乙烯酮缩胺类化合物的合成及生物活性

新烟碱类杀虫剂由于具有高效、低毒、无交互抗性和内吸性等特点,成为杀虫剂领域新的研究热点［１］．本文以Ｎｉｔｅｎｐｙｒａｍ为母体,首次合成了２－氰基－３－（２－氯－５－吡啶甲氨基）－３－甲硫基丙烯腈（９）,并以其为中间体合成了１９个双氰基取代的含２－氯...     

N-(5-氯-2-羟苯基)氨基酸酯的合成、表征及抑菌活性

以5-Cl水杨醛和L-苯丙氨酸、L-亮氨酸及L-甘氨酸的脂肪酸酯为原料,通过碱催化的席夫碱缩合反应,合成了6种N-（5-氯-2-羟苄基）席夫碱氨基酸酯及其还原产物N-（5-氯-2-羟苄基）氨基酸酯。 化合物的结构及组成经过IR、¹H NMR和元素分析测试技术进行了表征。 合成的席夫碱及其还原产物对革兰氏阴性菌、革兰氏阳性菌及真菌均有不同程度的抑制作用。 质量分数为0.01%的N-（5-氯-2-羟苄基）席夫碱氨基酸酯对大肠杆菌的抑菌率达90%以上,而N-（5-氯-2-羟苄基）氨基酸酯对金黄色葡萄球菌的抑菌率也在90%以上,均为强抑菌活性,其中N-（5-氯-2-羟苄基）苯丙氨酸酯的抑菌率达98%以上。